Compounded semaglutide: Where It Stands in 2026
Compounded semaglutide is Semaglutide made by a compounding pharmacy rather than the approved brand-name pen. Where it stands with the FDA in 2026, and what to check.
At a glance
- Semaglutide (brand-name drug)
- FDA approved (Ozempic, Wegovy, Rybelsus)
- Compounded version
- Not FDA approved
- Compounded drugs are not reviewed by the FDA for safety or effectiveness.
What changed in 2026
- FDA warning letters to five research-peptide sellersEnforcement
- FDA proposes excluding semaglutide, tirzepatide and liraglutide from the 503B bulks listFDA
- Seven FDA warning letters to online sellers of GLP-1 productsEnforcement
Telehealth brands people search with Semaglutide
Based on search data only: it shows what people look for, not which brands currently prescribe compounded versions.
| Brand | Price / month | Peptides offered | States | Link |
|---|---|---|---|---|
| Ro | Not stated | Not stated | Not stated | — |
| Hers | Not stated | Not stated | Not stated | — |
| WW (WeightWatchers) | Med+ membership: $25 first month, then $74/mo (12-month plan) or $84/mo (6-month plan); medication billed separatelyChecked 2 Oct 2026 | Wegovy, Saxenda, Zepbound, Foundayo | Not stated | — |
| Noom | $79 to start, then $179/mo (billed quarterly, medication included); higher GLP-1 tiers up to $299/mo; branded-medication plan $39 to start, then $129/mo, medication not includedChecked 2 Oct 2026 | GLP-1 programs (drug and compounding status not stated by tier), Branded GLP-1 (prescription only) | Not available in all 50 states (list not given on page) | — |
| Hims | Not stated | Not stated | Not stated | — |
| Fridays | Semaglutide from $117/mo, tirzepatide from $198/mo (promotional pricing as shown); brand Ozempic $1,498/mo, Zepbound $1,828/moChecked 2 Oct 2026 | Semaglutide (compounded and brand), Tirzepatide (compounded and brand) | Not stated | — |
| Eden | Not stated | Not stated | Not stated | — |
| Shed | Compounded semaglutide from $159/mo, compounded tirzepatide from $239/moChecked 2 Oct 2026 | Compounded semaglutide, Compounded tirzepatide, Wegovy, Zepbound, Sermorelin, NAD+ | All 50 states; treatment availability may vary by state | — |
| Found | Plans from $99/mo with insurance or $169/mo cash; medication included on compounded plansChecked 2 Oct 2026 | Compounded tirzepatide, Compounded semaglutide, Wegovy, Zepbound, Ozempic, Mounjaro | Not available in all states (full list not given) | — |
| Mochi Health | Membership $79/mo plus medication (compounded tirzepatide "as low as" $90, compounded semaglutide "as low as" $60)Checked 2 Oct 2026 | Compounded tirzepatide, Compounded semaglutide, Zepbound, Wegovy, Mounjaro, Ozempic | Availability and pricing vary by state (list not given) | — |
| Emerge | Not stated | Not stated | Not stated | — |
| Maximus | Compounded tirzepatide from $249.99/mo (2-month plan); brand-name GLP-1s from $199.99 (period not stated)Checked 2 Oct 2026 | Compounded tirzepatide, Wegovy, Zepbound, Ozempic, Mounjaro, Testosterone | Not stated | — |
| AgelessRx | Microdosing tirzepatide from $159/mo, microdosing semaglutide from $99/mo, sermorelin from $99/moChecked 2 Oct 2026 | Microdosing tirzepatide, Microdosing semaglutide, Sermorelin, NAD+ injection | Not stated | — |
| Sesame | Wegovy pill from $149/month; visits from $34Checked 2 Oct 2026 | Wegovy, Zepbound, Ozempic, Mounjaro, Rybelsus | Not stated | — |
| TrimRx | Not stated | Not stated | Not stated | — |
| LifeMD | Wegovy from $149 (billing period not stated)Checked 2 Oct 2026 | Wegovy, Compounded GLP-1 (where the provider prescribes) | Not stated | — |
| Ways2Well | $99 one-time peptide consult; peptides billed separatelyChecked 2 Oct 2026 | Not stated | 43 states and DC listed on its page; restrictions in some (CA, OH, NV: weight-loss peptides only) | — |
| Calibrate | $199/mo Metabolic Reset program (3-month minimum)Checked 2 Oct 2026 | Wegovy, Ozempic, Mounjaro, Zepbound | Not stated | — |
| SkinnyRx | From $99 for the first month (injectables); ongoing price not statedChecked 2 Oct 2026 | Tirzepatide injection, Semaglutide injection, Wegovy pill | Not stated | — |
| IVIM Health | Compounded tirzepatide $133/mo and compounded semaglutide $75/mo (6-month plans); membership $75/mo, first month freeChecked 2 Oct 2026 | Compounded tirzepatide, Compounded semaglutide, Zepbound, Wegovy, Sermorelin (coming soon) | Not stated | — |
| Push Health | Not stated | Not stated | Not stated | — |
| Juniper | Not stated | Not stated | Not stated | — |
What FDA says about compounded semaglutide
FDA says compounded drugs should be used only for patients whose medical needs an approved drug cannot meet.[4]
As of May 31, 2026 FDA had received 990 adverse event reports tied to compounded semaglutide.[4]
FDA says semaglutide sodium and acetate, sold by some compounders, are different active ingredients from the approved drug.[4]
FDA treats a semaglutide and vitamin B12 product as essentially a copy of an approved drug when the route is the same and the amounts are within 10% of the approved strengths.[5]
What two telehealth pages quote for it
One telehealth page lists compounded semaglutide as low as $60, with no billing period stated.[6]
Another telehealth page lists compounded semaglutide as low as $159 a month.[7]
Spread between the quoted prices
The two advertised starting prices differ by $99, and the higher is 2.65 times the lower. One quote has no billing period and the other says per month, so they may not be like for like.
Calculated from first page starting price 60; second page starting price 159. Formula: 159-60=99; 159/60=2.65
Common questions
What is compounded semaglutide?
FDA describes it as an unapproved version, made without FDA review of safety, effectiveness or quality before marketing.[4]
Is compounded semaglutide with B12 treated differently?
FDA uses it as its example of a product it may regard as essentially a copy of a commercially available drug.[5]
Sources
- 1FDA warning letters to five research-peptide sellersFDA warning letter (NuScience Peptides; 1 of 5) · 2026fda.govAccessed 2 Oct 2026
- 2FDA proposes excluding semaglutide, tirzepatide and liraglutide from the 503B bulks listFDA · 2026fda.govAccessed 2 Oct 2026
- 3Seven FDA warning letters to online sellers of GLP-1 productsFDA warning letter (Gram Peptides; 1 of 7) · 2026fda.govAccessed 2 Oct 2026
- 4Official web pageOfficial web page · web page
- 5Official web pageOfficial web page · web page
- 6Official web pageOfficial web page · web page
- 7Official web pageOfficial web page · web page
Found an error? Report a correction.